Harvard engineers have pioneered a unique wearable robot that adapts to user movements, providing personalised assistance to enhance daily activities for stroke and ALS patients.
Svein Olaf Olsen and Maiken Arnesen from the European Huntington Association reveal their thoughts on a recent and significant breakthrough concerning Huntington’s Disease (HD)...
UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's
Neurodegenerative diseases are...
The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s
My PD Journey is a multi-stakeholder...
Emory University’s Stuart Zola considers the case for classifying Alzheimer’s disease as a spectrum disorder and the promise of precision medicine as an intervention.
The defect that causes Huntington's disease has been corrected in patients for the first time with an experimental drug
Experts believe that the new experimental drug, which...
Ai-Ling Lin PhD, of The Lin Brain Lab talks about the reversal of cognitive decline in Alzheimer’s disease with comprehensive and personalised nutrition
Alzheimer’s disease...
Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s
Frederic Destrebecq, Vinciane Quoidbach and Alison Turner at the European Brain Council discuss improvements in stroke care, awareness-raising and early detection
Stroke is a leading...
Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research
Parkinson's disease is a slow but progressive...
The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance
This will...
